Marinomed Biotech AG 2022 Annual Report with Sustainability Disclosures
The report highlights Marinomed Biotech AG's successful fiscal year 2022, featuring stable revenues of EUR 11.3 million, driven by a 15.5% double-digit growth in Carragelose revenues. Key milestones included signing a partnership agreement with Procter & Gamble for Carragelose in the U.S. market and expanding Solv4U technology partnerships. On the sustainability front, the company reduced its gas consumption by 54.8% and expanded its photovoltaic system to cover 16% of its electricity consumption. Additionally, Marinomed ranked third in the Gender Diversity Index Austria 2022 and continued its commitment to sustainable development across environmental, social, and governance areas.
Company: Marinomed Biotech AG
Sector: Manufacturing
Country: Austria
Year: 2022
Type: Annual Report with Sustainability Disclosures
Pages: 146
Marinomed Biotech AG
The report highlights Marinomed Biotech AG's successful fiscal year 2022, featuring stable revenues of EUR 11.3 million, driven by a 15.5% double-digit growth in Carragelose revenues. Key milestones included signing a partnership agreement with Procter & Gamble for Carragelose in the U.S. market and expanding Solv4U technology partnerships. On the sustainability front, the company reduced its gas consumption by 54.8% and expanded its photovoltaic system to cover 16% of its electricity consumption. Additionally, Marinomed ranked third in the Gender Diversity Index Austria 2022 and continued its commitment to sustainable development across environmental, social, and governance areas.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Published
Apr 18, 2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees